أرسل هذا في رسالة قصيرة: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 _    _      ___      _____     ______    _____   
| |  | ||   / _ \\   /  ___||  /_   _//  /  ___|| 
| |/\| ||  | / \ || | // __     -| ||-  | // __   
|  /\  ||  | \_/ || | \\_\ ||   _| ||_  | \\_\ || 
|_// \_||   \___//   \____//   /_____//  \____//  
`-`   `-`   `---`     `---`    `-----`    `---`